Literature DB >> 16158059

Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.

Charles Reichman1, Kamalendra Singh, Yan Liu, Sukhwinder Singh, Hong Li, J Eduardo Fajardo, Andras Fiser, Raymond B Birge.   

Abstract

To gain a better understanding of how Crk II regulates the function of the Abl tyrosine kinase, we explored the function of the C-terminal linker and SH3 domain, a region of Crk II that is still poorly understood. Molecular modeling, tryptophan fluorescence, and covariation sequence alignment indicate that the Crk-SH3-C has a unique binding groove and RT loop not observed in typical SH3 domains. Based on these models, we made a series of mutations in the linker and in residues predicted to destabilize the putative binding pocket and RT loop. In Abl transactivation assays, Y222F and P225A mutations in the linker resulted in strong transactivation of Abl by Crk II. However, mutations predicted to be at the surface of the Crk SH3-C were not activators of Abl. Interestingly, combinations of activating mutations of Crk II with mutations in the highly conserved PNAY sequence in the SH3-C inactivated the activating mutations, suggesting that the SH3-C is necessary for activation. Our data provide insight into the role of highly conserved residues in the Crk-SH3-C, suggesting a mechanism for how the linker and the Crk-SH3-C function in the transactivation of the Abl tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158059     DOI: 10.1038/sj.onc.1208988

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.

Authors:  G Sriram; C Reichman; A Tunceroglu; N Kaushal; T Saleh; K Machida; B Mayer; Q Ge; J Li; P Hornbeck; C G Kalodimos; R B Birge
Journal:  Oncogene       Date:  2011-05-23       Impact factor: 9.867

Review 2.  SH3 domains: modules of protein-protein interactions.

Authors:  Natalya Kurochkina; Udayan Guha
Journal:  Biophys Rev       Date:  2012-06-20

3.  Cardiovascular and craniofacial defects in Crk-null mice.

Authors:  Tae-Ju Park; Kelli Boyd; Tom Curran
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 4.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

5.  Roles for crk in cancer metastasis and invasion.

Authors:  Masumi Tsuda; Shinya Tanaka
Journal:  Genes Cancer       Date:  2012-05

6.  Models of crk adaptor proteins in cancer.

Authors:  Emily S Bell; Morag Park
Journal:  Genes Cancer       Date:  2012-05

7.  Proline cis-trans isomerization controls autoinhibition of a signaling protein.

Authors:  Paramita Sarkar; Charles Reichman; Tamjeed Saleh; Raymond B Birge; Charalampos G Kalodimos
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

8.  Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts.

Authors:  William D Bradley; Anthony J Koleske
Journal:  J Cell Sci       Date:  2009-10-01       Impact factor: 5.285

9.  Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.

Authors:  Raymond B Birge; Charalampos Kalodimos; Fuyuhiko Inagaki; Shinya Tanaka
Journal:  Cell Commun Signal       Date:  2009-05-10       Impact factor: 5.712

10.  A proposed syntax for Minimotif Semantics, version 1.

Authors:  Jay Vyas; Ronald J Nowling; Mark W Maciejewski; Sanguthevar Rajasekaran; Michael R Gryk; Martin R Schiller
Journal:  BMC Genomics       Date:  2009-08-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.